Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Rhabdomyosarcoma, Embryonal × dinutuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 4 Ganglioneuroblastoma 2 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Bone Neoplasms 1

Interventions

Vincristine 2 Radiotherapy 2 Radiation 2 Dactinomycin 2 Cyclophosphamide 2 temsirolimus 1 dinutuximab 1 Vinorelbine 1 Sirolimus 1 Magnetic Resonance Spectroscopy 1 Irinotecan 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06669013 2024-11-01

FollowTheDIN

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Recruiting

Bone Neoplasms, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡